Strontium-89 (Metastron)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 18:28, 7 April 2023 by Jwarner (talk | contribs)
Jump to navigation Jump to search

General information

Radioactive strontium

Diseases for which it was used

History of changes in FDA indication

  • 1993-06-18: Initial approval for the relief of bone pain in patients with painful skeletal metastases.

Also known as

  • Brand name: Metastron
Retrieved from "https://hemonc.org/w/index.php?title=Strontium-89_(Metastron)&oldid=67714"